Filing Details
- Accession Number:
- 0001209191-18-055127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-16 16:30:52
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-16 16:30:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511368 | G Lawrence Hamel | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-15 | 5,216 | $5.00 | 29,795 | No | 4 | S | Indirect | By the Hamel Revocable Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By the Hamel Revocable Living Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,371 | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
Billionaire Hedge Funds
